Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
Working Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Working Capital/Sales(x) 2.313.244.014.89177.75

What is the latest Working Capital/Sales ratio of VENUS REMEDIES ?

The latest Working Capital/Sales ratio of VENUS REMEDIES is 2.31 based on Mar2023 Consolidated results.
Year Working Capital/Sales
Mar20232.31
Mar20223.24
Mar20214.01
Mar20204.89
Mar2019177.75

How is Working Capital/Sales of VENUS REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2023 2.31
-28.70
Mar2022 3.24
-19.20
Mar2021 4.01
-18.00
Mar2020 4.89
-97.25
Mar2019 177.75 -

Other Financial Ratios of VENUS REMEDIES


Compare Working Capital/Sales ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹399.3 Cr -4.6% -13.8% 49.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹370,757.0 Cr 0.7% -4.8% 57.3% Stock Analytics
CIPLA ₹109,559.0 Cr 1.9% -2.4% 42.6% Stock Analytics
DIVIS LABORATORIES ₹103,416.0 Cr 0.1% 3% 12.1% Stock Analytics
ZYDUS LIFESCIENCES ₹99,088.9 Cr 1.3% 0.5% 87.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,939.0 Cr -5.4% -4.1% 20% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-4.6%

-13.8%

49.4%

SENSEX

-0.6%

-2.1%

18.4%


You may also like the below Video Courses